ATR inhibitor program (Chengdu Easton Biopharmaceuticals)

ATR抑制剂 (成都苑东生物)

Report date: 2025/03/04 16:59:50
NME

Base Information

Drug NameATR inhibitor program (Chengdu Easton Biopharmaceuticals)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSerine-protein kinase ATR inhibitors
TargetsSerine-protein kinase ATR
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesChengdu Easton Biopharmaceuticals Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesChengdu Easton Biopharmaceuticals Co Ltd
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A